NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company's products include food safety testing kits, including DR. Meat Kit, DR. Food-Ent kit, rapid test kit, and ELISA kit; infectious disease testing, such as DR. HPV Genotyping IVD Kit, DR. MTBC Screen IVD Kit, and DR. Microorganism IVD Kit (Non-sterile); and biochip instruments and equipment, including DR. AiM Reader, DR.Mini Oven, and DR.Fluidic Station. In addition, the company engages in the wholesale and retail of contact lenses. The company was formerly known as DR. Chip Biotechnology Incorporation and changed its name to NeoCore Technology Co., Ltd. in July 2023. NeoCore Technology Co., Ltd. was founded in 1987 and is headquartered in Tainan City, Taiwan.
Frequently asked questions
What sector does NeoCore Technology Co., Ltd. (4131) operate in?
NeoCore Technology Co., Ltd. belongs to the Other sector and operates in the Biotechnology industry.
What is NeoCore Technology Co., Ltd. (4131) current stock price?
As of the latest data, NeoCore Technology Co., Ltd. stock price is NT$32.20, with a previous close of NT$32.20.
What is NeoCore Technology Co., Ltd. (4131) current market capitalization?
NeoCore Technology Co., Ltd. market cap is approximately 1.28 billion.
What is NeoCore Technology Co., Ltd. (4131) Earnings Per Share (EPS)?
The trailing EPS is -NT$0.52.
Does NeoCore Technology Co., Ltd. (4131) pay dividends?
No. NeoCore Technology Co., Ltd. does not pay a dividend.
What is NeoCore Technology Co., Ltd. (4131) beta (volatility) score?
NeoCore Technology Co., Ltd. has a beta of -0.266, indicating lower volatility than the overall market.
